CD4 and infection: The results (Fig. 2a, b) showed that patients with moderate disease who cleared the virus early and recovered rapidly had the highest number of virus-specific CD4+ T cells in the early (7–14 dps) and middle stages (14–21 dps) post-infection, significantly higher than critically ill patients (P < 0.05), and also trendily higher than that of severe patients.